Veracyte Inc (VCYT)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Veracyte Inc-Aktie (VCYT)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-03-31	2023-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	13.71% 130.16	114.47	115.86	96.84	98.20
Cost Of Revenue	15.53% 40.40	34.97	36.85	-	-
Gross Profit	12.91% 89.77	79.51	79.01	-	-
Operating Expenses	24.06% 95.04	76.60	66.99	101.50	133.71
Benefits Costs and Expenses	20.43% 128.91	107.05	99.01	98.75	128.67
Costs And Expenses	24.06% 95.04	76.60	66.99	101.50	133.71
Operating Income/Loss	281.40% -5.268	2.904	12.02	-4.656	-35.51
Income/Loss From Continuing Operations Before Tax	83.17% 1.25	7.428	16.85	-1.908	-30.47
Income Tax Expense/Benefit	485.30% 2.23	0.381	1.693	-0.044	-2.179
Income/Loss From Continuing Operations After Tax	113.91% -0.98	7.047	15.15	-1.864	-28.29
Net Income/Loss	113.91% -0.98	7.047	15.15	-1.864	-28.29
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.47% 78.39	78.03	77.01	74.76	0.1559
Diluted Average Shares	2.08% 78.39	80.06	78.46	74.76	0.1559
Basic Earnings Per Share	111.11% -0.01	0.09	0.20	-0.02	-0.38
Diluted Earnings Per Share	111.11% -0.01	0.09	0.19	-0.02	-0.38
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

DGX

$178.84

1.64%

WAT

$345.59

1.15%

$257.84

1.53%

NTRA

$198.23

0.35%

MTD

$1,406.88

0.66%

IQV

$213.88

1.19%